300138 晨光生物
已收盘 03-12 15:00:00
资讯
新帖
简况
晨光生物涨7.75%，西南证券一个月前给出“买入”评级
证券之星 · 03-12 16:24
晨光生物涨7.75%，西南证券一个月前给出“买入”评级
晨光生物（300138）披露为参股公司银行借款提供担保的进展公告，3月10日股价下跌0.41%
证券之星 · 03-10 22:27
晨光生物（300138）披露为参股公司银行借款提供担保的进展公告，3月10日股价下跌0.41%
晨光生物最新公告：2025年度净利润同比增长286.65%
证券之星 · 02-27
晨光生物最新公告：2025年度净利润同比增长286.65%
晨光生物：公司异绿原酸钠向市场正常出货中
证券之星 · 02-12
晨光生物：公司异绿原酸钠向市场正常出货中
股市必读：晨光生物（300138）2月3日董秘有最新回复
证券之星 · 02-04
股市必读：晨光生物（300138）2月3日董秘有最新回复
晨光生物：主要产品广泛应用于食品饮料、调味品、营养保健、医药、香精香料、动保及饲料蛋白等领域
证券之星 · 02-03
晨光生物：主要产品广泛应用于食品饮料、调味品、营养保健、医药、香精香料、动保及饲料蛋白等领域
晨光生物：1200吨/年原料药项目由公司原合并报表范围内子公司晨光天润制药负责实施
证券之星 · 01-29
晨光生物：1200吨/年原料药项目由公司原合并报表范围内子公司晨光天润制药负责实施
晨光生物（300138）披露为子公司银行借款提供担保的进展公告，1月26日股价上涨0.22%
证券之星 · 01-26
晨光生物（300138）披露为子公司银行借款提供担保的进展公告，1月26日股价上涨0.22%
股市必读：晨光生物（300138）1月22日董秘有最新回复
证券之星 · 01-23
股市必读：晨光生物（300138）1月22日董秘有最新回复
股市必读：晨光生物（300138）1月20日董秘有最新回复
证券之星 · 01-21
股市必读：晨光生物（300138）1月20日董秘有最新回复
晨光生物（300138）披露高级管理人员股份减持计划实施完毕公告，1月19日股价上涨0.88%
证券之星 · 01-19
晨光生物（300138）披露高级管理人员股份减持计划实施完毕公告，1月19日股价上涨0.88%
西南证券：给予晨光生物买入评级
证券之星 · 01-19
西南证券：给予晨光生物买入评级
晨光生物：1月16日高管李凤飞减持股份合计14万股
证券之星 · 01-19
晨光生物：1月16日高管李凤飞减持股份合计14万股
晨光生物(300138.SZ)：拟成立全资子公司开展罗汉果加工提取业务
中金财经 · 01-16
晨光生物(300138.SZ)：拟成立全资子公司开展罗汉果加工提取业务
晨光生物（300138）披露为子公司银行借款提供担保的进展公告，1月15日股价下跌2.18%
证券之星 · 01-15
晨光生物（300138）披露为子公司银行借款提供担保的进展公告，1月15日股价下跌2.18%
晨光生物涨5.67%，华鑫证券二个月前给出“买入”评级
证券之星 · 01-14
晨光生物涨5.67%，华鑫证券二个月前给出“买入”评级
最高猛增520%！A股批量晒出超级“战报”，一晚7家官宣净利翻倍
券商中国 · 01-14
最高猛增520%！A股批量晒出超级“战报”，一晚7家官宣净利翻倍
股市必读：晨光生物（300138）预计2025年全年扣非后净利润盈利2.74亿元至3.29亿元
证券之星 · 01-14
股市必读：晨光生物（300138）预计2025年全年扣非后净利润盈利2.74亿元至3.29亿元
晨光生物最新公告：2025年净利同比预增272.14%-330.62%
证券之星 · 01-13
晨光生物最新公告：2025年净利同比预增272.14%-330.62%
每周股票复盘：晨光生物（300138）子公司获高新认证享税收优惠
证券之星 · 01-03
每周股票复盘：晨光生物（300138）子公司获高新认证享税收优惠
加载更多
公司概况
公司名称：
晨光生物科技集团股份有限公司
所属行业：
农副食品加工业
上市日期：
2010-11-05
主营业务：
晨光生物科技集团股份有限公司的主营业务是天然植物提取物的生产、销售。公司的主要产品是天然色素、天然香辛料提取物和精油、天然营养及药用提取物、天然甜味剂、保健食品、油脂和蛋白。
发行价格：
30.00
{"stockData":{"symbol":"300138","market":"SZ","secType":"STK","nameCN":"晨光生物","latestPrice":15.71,"timestamp":1773299007000,"preClose":14.58,"halted":0,"volume":28190618,"delay":0,"changeRate":0.0775,"floatShares":398000000,"shares":483000000,"eps":0.6941,"marketStatus":"已收盘","change":1.13,"latestTime":"03-12 15:00:00","open":14.5,"high":15.8,"low":14.46,"amount":434000000,"amplitude":0.0919,"askPrice":15.72,"askSize":819,"bidPrice":15.71,"bidSize":163,"shortable":0,"etf":0,"ttmEps":0.6941,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773365400000},"marketStatusCode":5,"adr":0,"adjPreClose":14.58,"symbolType":"stock","openAndCloseTimeList":[[1773279000000,1773286200000],[1773291600000,1773298800000]],"highLimit":16.04,"lowLimit":13.12,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":483100093,"isCdr":false,"pbRate":2.11,"roa":"--","peRate":22.633626,"roe":"9.4%","epsLYR":0.1818,"committee":-0.665238,"marketValue":7590000000,"turnoverRate":0.0708,"status":0,"floatMarketCap":6258000000},"requestUrl":"/m/hq/s/300138","defaultTab":"news","newsList":[{"id":"2618278181","title":"晨光生物涨7.75%，西南证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2618278181","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618278181?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:24","pubTimestamp":1773303876,"startTime":"0","endTime":"0","summary":"今日晨光生物涨7.75%，收盘报15.71元。2026年1月19日，西南证券研究员朱会振,杜雨聪发布了对晨光生物的研报《业绩大超预期，产品多点开花》，该研报对晨光生物给出“买入”评级。研报中预计2025-2027年归母净利润分别为3.8、5.0、6.4亿元，EPS分别为0.79元、1.03元、1.33元，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中泰证券的罗影。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200026080.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","600369"],"gpt_icon":0},{"id":"2618959753","title":"晨光生物（300138）披露为参股公司银行借款提供担保的进展公告，3月10日股价下跌0.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618959753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618959753?lang=zh_cn&edition=full","pubTime":"2026-03-10 22:27","pubTimestamp":1773152839,"startTime":"0","endTime":"0","summary":"截至2026年3月10日收盘，晨光生物报收于14.44元，较前一交易日下跌0.41%，最新总市值为69.76亿元。公司于近日披露《关于为参股公司银行借款提供担保的进展公告》。公告显示，晨光生物科技集团股份有限公司于2025年4月3日召开董事会、2025年5月6日召开年度股东大会，审议通过为参股公司新疆晨丰源油脂有限公司银行借款提供担保的议案。截至目前，公司对合并报表外参股公司已签订担保协议余额为258.25万元，占公司最近一期经审计净资产的0.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000038480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","BK0238"],"gpt_icon":0},{"id":"2614834066","title":"晨光生物最新公告：2025年度净利润同比增长286.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614834066","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614834066?lang=zh_cn&edition=full","pubTime":"2026-02-27 18:49","pubTimestamp":1772189377,"startTime":"0","endTime":"0","summary":"晨光生物(300138.SZ)公告称，晨光生物发布2025年度业绩快报，营业总收入65.64亿元，同比下降6.15%；归属于上市公司股东的净利润3.64亿元，同比增长286.65%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700034024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138"],"gpt_icon":0},{"id":"2610802992","title":"晨光生物：公司异绿原酸钠向市场正常出货中","url":"https://stock-news.laohu8.com/highlight/detail?id=2610802992","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610802992?lang=zh_cn&edition=full","pubTime":"2026-02-12 11:35","pubTimestamp":1770867320,"startTime":"0","endTime":"0","summary":"证券之星消息，晨光生物(300138)02月11日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的异绿原酸钠已经去年12月上市销售。目前销售情况如何晨光生物回复：您好，公司异绿原酸钠向市场正常出货中，由于上市时间较短，目前该产品的相关收入占总体营收比重较小，后续将会积极开拓市场。有关产品经营情况请届时关注定期报告相关内容。谢谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200014496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","300138"],"gpt_icon":0},{"id":"2608804196","title":"股市必读：晨光生物（300138）2月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2608804196","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608804196?lang=zh_cn&edition=full","pubTime":"2026-02-04 02:57","pubTimestamp":1770145029,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，晨光生物报收于13.52元，上涨1.12%，换手率2.25%，成交量8.95万手，成交额1.2亿元。董秘最新回复投资者： 请问公司的下游主要涉及哪些行业，包括哪些知名公司？关于客户信息，因涉及商业机密，不便具体透露。当日关注点来自交易信息汇总：2月3日主力资金净流入119.17万元，游资积极介入，散户资金呈净流出态势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400001717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","BK0238"],"gpt_icon":0},{"id":"2608182681","title":"晨光生物：主要产品广泛应用于食品饮料、调味品、营养保健、医药、香精香料、动保及饲料蛋白等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2608182681","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608182681?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:42","pubTimestamp":1770108129,"startTime":"0","endTime":"0","summary":"证券之星消息，晨光生物(300138)02月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司的下游主要涉及哪些行业，包括哪些知名公司？晨光生物回复：您好，公司主要产品广泛应用于食品饮料、调味品、营养保健、医药、香精香料、动保及饲料蛋白等领域。关于客户信息，因涉及商业机密，不便具体透露。谢谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300028118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159843","BK1574","BK1515","BK0238","BK1161","300138","000807.SH","159938","09939"],"gpt_icon":0},{"id":"2607727870","title":"晨光生物：1200吨/年原料药项目由公司原合并报表范围内子公司晨光天润制药负责实施","url":"https://stock-news.laohu8.com/highlight/detail?id=2607727870","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607727870?lang=zh_cn&edition=full","pubTime":"2026-01-29 08:51","pubTimestamp":1769647867,"startTime":"0","endTime":"0","summary":"证券之星消息，晨光生物01月28日在投资者关系平台上答复投资者关心的问题。什么，预计什么时候可以完工？晨光生物回复：您好，1200吨/年原料药项目由公司原合并报表范围内子公司晨光天润制药负责实施。为优化资产结构，公司已将所持晨光天润制药97.5%股权转让给四川同晟生物医药有限公司，转让完成后晨光天润制药不再纳入公司合并报表范围，详情可以查阅巨潮资讯网披露的相关公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900006780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1191","300138","01477","BK0238"],"gpt_icon":0},{"id":"2606665249","title":"晨光生物（300138）披露为子公司银行借款提供担保的进展公告，1月26日股价上涨0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606665249","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606665249?lang=zh_cn&edition=full","pubTime":"2026-01-26 22:47","pubTimestamp":1769438875,"startTime":"0","endTime":"0","summary":"截至2026年1月26日收盘，晨光生物报收于13.95元，较前一交易日上涨0.22%，最新总市值为67.39亿元。公司于2026年1月26日披露《关于为子公司银行借款提供担保的进展公告》。公告显示，晨光生物科技集团股份有限公司于2025年4月3日和5月6日分别召开董事会及年度股东大会，审议通过为子公司提供融资担保的议案，授权管理层在担保余额不超过25亿元的前提下调整具体担保安排。公司及子公司无逾期对外担保情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600036717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","BK0238"],"gpt_icon":0},{"id":"2605416089","title":"股市必读：晨光生物（300138）1月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605416089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605416089?lang=zh_cn&edition=full","pubTime":"2026-01-23 01:49","pubTimestamp":1769104150,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘，晨光生物报收于14.0元，上涨0.65%，换手率2.58%，成交量10.27万手，成交额1.44亿元。董秘： 您好，公司已于2025年12月29日正式获得异绿原酸钠作为新型饲料添加剂的生产许可批准，目前向市场正常出货中。当日关注点来自交易信息汇总：1月22日主力资金净流出963.36万元，游资资金净流出1095.24万元，散户资金净流入2058.6万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300000930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","BK0238"],"gpt_icon":0},{"id":"2605314390","title":"股市必读：晨光生物（300138）1月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605314390","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605314390?lang=zh_cn&edition=full","pubTime":"2026-01-21 02:24","pubTimestamp":1768933450,"startTime":"0","endTime":"0","summary":"截至2026年1月20日收盘，晨光生物报收于14.2元，上涨3.35%，换手率6.18%，成交量24.63万手，成交额3.47亿元。董秘最新回复投资者： 建议今年公司再搞1亿元回购并注销。交易信息汇总资金流向1月20日主力资金净流出838.82万元；游资资金净流出941.92万元；散户资金净流入1780.75万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100001031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","BK0238"],"gpt_icon":0},{"id":"2604131550","title":"晨光生物（300138）披露高级管理人员股份减持计划实施完毕公告，1月19日股价上涨0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604131550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604131550?lang=zh_cn&edition=full","pubTime":"2026-01-19 22:30","pubTimestamp":1768833041,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘，晨光生物报收于13.74元，较前一交易日上涨0.88%，最新总市值为66.38亿元。公司于近日发布公告称，高级管理人员李凤飞于2026年1月16日通过集中竞价交易方式减持公司股份140,000股，占公司总股本0.03%，减持均价为13.69元/股。本次减持计划已实施完毕，减持数量未超过此前预披露的减持计划上限。减持后，李凤飞合计持有公司股份427,883股，占总股本0.09%。本次减持符合相关法律法规要求，未导致公司控制权变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900035847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","300138"],"gpt_icon":0},{"id":"2604318706","title":"西南证券：给予晨光生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2604318706","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604318706?lang=zh_cn&edition=full","pubTime":"2026-01-19 18:31","pubTimestamp":1768818707,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司朱会振,杜雨聪近期对晨光生物进行研究并发布了研究报告《业绩大超预期，产品多点开花》，给予晨光生物买入评级。 盈利预测与投资建议：预计2025-2027年归母净利润分别为3.8、5.0、6.4亿元，EPS分别为0.79元、1.03元、1.33元，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有9家机构给出评级，买入评级6家，增持评级3家；过去90天内机构目标均价为17.76。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900028255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","600369"],"gpt_icon":0},{"id":"2604818201","title":"晨光生物：1月16日高管李凤飞减持股份合计14万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604818201","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604818201?lang=zh_cn&edition=full","pubTime":"2026-01-19 18:02","pubTimestamp":1768816926,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月19日市场公开信息、上市公司公告及交易所披露数据整理，晨光生物最新董监高及相关人员股份变动情况：2026年1月16日公司副总裁李凤飞共减持公司股份14.0万股，占公司总股本为0.029%。晨光生物近半年内的董监高及核心技术人员增减持详情如下：晨光生物的高管列表及最新持股情况如下：该股最近90天内共有9家机构给出评级，买入评级6家，增持评级3家；过去90天内机构目标均价为17.76。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900024915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","300138"],"gpt_icon":0},{"id":"2603296484","title":"晨光生物(300138.SZ)：拟成立全资子公司开展罗汉果加工提取业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2603296484","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603296484?lang=zh_cn&edition=full","pubTime":"2026-01-16 17:47","pubTimestamp":1768556822,"startTime":"0","endTime":"0","summary":"格隆汇1月16日丨晨光生物(300138.SZ)公布，根据公司战略发展需要，为拓展公司业务，合理完善产业布局，公司拟使用自有资金8000万元在桂林市成立全资子公司，开展罗汉果加工提取业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260116/31948996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0238","300138"],"gpt_icon":0},{"id":"2603986797","title":"晨光生物（300138）披露为子公司银行借款提供担保的进展公告，1月15日股价下跌2.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603986797","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603986797?lang=zh_cn&edition=full","pubTime":"2026-01-15 22:40","pubTimestamp":1768488025,"startTime":"0","endTime":"0","summary":"截至2026年1月15日收盘，晨光生物报收于13.48元，较前一交易日下跌2.18%，最新总市值为65.12亿元。该股当日开盘13.57元，最高13.7元，最低13.41元，成交额达2.38亿元，换手率为4.42%。晨光生物科技集团股份有限公司近日发布公告，披露公司为子公司银行借款提供担保的最新进展。公司及子公司无逾期对外担保情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500041224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","300138"],"gpt_icon":0},{"id":"2603698390","title":"晨光生物涨5.67%，华鑫证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2603698390","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603698390?lang=zh_cn&edition=full","pubTime":"2026-01-14 15:39","pubTimestamp":1768376352,"startTime":"0","endTime":"0","summary":"今日晨光生物（300138）涨5.67%，收盘报13.78元。2025年10月28日，华鑫证券研究员孙山山,张倩发布了对晨光生物的研报《公司事件点评报告：价格拐点初显，盈利能力加速释放》，该研报对晨光生物给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为57.93%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中泰证券的罗𬱖影。晨光生物（300138）个股概况：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400020710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300138"],"gpt_icon":0},{"id":"1160240254","title":"最高猛增520%！A股批量晒出超级“战报”，一晚7家官宣净利翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1160240254","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160240254?lang=zh_cn&edition=full","pubTime":"2026-01-14 07:53","pubTimestamp":1768348426,"startTime":"0","endTime":"0","summary":"2025年第四季度单季度归属于母公司所有者的净利润预计为8.196亿元至9.696亿元，同比增长1225.40%至1449.67%，环比增长219.89%至278.43%。多家A股公司业绩翻倍1月13日晚间，预计2025年净利同比大幅增长的公司还有晨光生物、TCL科技、大族数控、沃华医药、豪鹏科技等。","market":"sh","thumbnail":"https://static.tigerbbs.com/6a8642475395bb363eacb86148917e7b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6a8642475395bb363eacb86148917e7b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"97f7f61f37ceb16be854a336559e76b5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300138","688525","000100"],"gpt_icon":1},{"id":"2603632357","title":"股市必读：晨光生物（300138）预计2025年全年扣非后净利润盈利2.74亿元至3.29亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603632357","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603632357?lang=zh_cn&edition=full","pubTime":"2026-01-14 02:45","pubTimestamp":1768329911,"startTime":"0","endTime":"0","summary":"截至2026年1月13日收盘，晨光生物报收于13.04元，上涨0.15%，换手率2.07%，成交量8.26万手，成交额1.08亿元。来自：晨光生物预计2025年扣非后净利润最高达3.29亿元，同比增长超519%。晨光生物发布业绩预告，预计2025年全年归属净利润盈利3.5亿元至4.05亿元。公司公告汇总2025年度业绩预告晨光生物预计2025年度归属于上市公司股东的净利润为35,000万元至40,500万元，同比增长272.14%至330.62%；扣除非经常性损益后的净利润为27,400万元至32,900万元，同比增长519.13%至643.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400001343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138"],"gpt_icon":0},{"id":"2603851516","title":"晨光生物最新公告：2025年净利同比预增272.14%-330.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603851516","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603851516?lang=zh_cn&edition=full","pubTime":"2026-01-13 19:40","pubTimestamp":1768304417,"startTime":"0","endTime":"0","summary":"晨光生物公告称，预计2025年归属于上市公司股东的净利润为3.50亿元—4.05亿元，比上年同期增长272.14%至330.62%。2025年，植提类业务实现的收入和毛利额同比增长，是公司发展的基石，其中辣椒红实现销量1万吨以上，同比增长约27%；辣椒精销量约2900吨，同比增长约65%；叶黄素销量约4.6亿克，同比略有下降。综上影响，公司整体业绩较上年同期上升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300036682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","BK0238"],"gpt_icon":0},{"id":"2600098382","title":"每周股票复盘：晨光生物（300138）子公司获高新认证享税收优惠","url":"https://stock-news.laohu8.com/highlight/detail?id=2600098382","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600098382?lang=zh_cn&edition=full","pubTime":"2026-01-03 04:14","pubTimestamp":1767384851,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，晨光生物报收于12.41元，较上周的12.72元下跌2.44%。本周，晨光生物12月29日盘中最高价报12.77元。本周关注点公司公告汇总：邯郸晨光、晨光检测及莎车晨光通过高新技术企业重新认定，未来三年按15%税率缴所得税。此前该笔贷款中5,000万元已归还，公司相应解除担保义务。公司及子公司无逾期对外担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","300138"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773347949185,"stockEarnings":[{"period":"1week","weight":0.1476},{"period":"1month","weight":0.1467},{"period":"3month","weight":0.239},{"period":"6month","weight":0.2122},{"period":"1year","weight":0.7277},{"period":"ytd","weight":0.2659}],"compareEarnings":[{"period":"1week","weight":0.005},{"period":"1month","weight":0.0002},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.0668},{"period":"1year","weight":0.2246},{"period":"ytd","weight":0.0404}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"晨光生物科技集团股份有限公司","boardCode":"AI0013","boardName":"农副食品加工业","stockholders":"16669人(较上一季度增加6.72%)","perCapita":"23895股","listingDate":"2010-11-05","address":"河北省邯郸市曲周县城晨光路1号","registeredCapital":"48310万元","survey":" 晨光生物科技集团股份有限公司的主营业务是天然植物提取物的生产、销售。公司的主要产品是天然色素、天然香辛料提取物和精油、天然营养及药用提取物、天然甜味剂、保健食品、油脂和蛋白。","listedPrice":30},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"晨光生物(300138)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供晨光生物(300138)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"晨光生物,300138,晨光生物股票,晨光生物股票老虎,晨光生物股票老虎国际,晨光生物行情,晨光生物股票行情,晨光生物股价,晨光生物股市,晨光生物股票价格,晨光生物股票交易,晨光生物股票购买,晨光生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"晨光生物(300138)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供晨光生物(300138)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}